Italian Experience



Autoimmune pancreatitis (AIP) is now a well-defined disease of the pancreas that differs clinically, radiologically, and therapeutically from all the other inflammatory diseases of the pancreas. It has been recently histologically classified in type 1 and type 2 AIPs, not different at imaging, but with a better clinical outcome in type 2 compared to type 1.

From a clinical point of view, the key point in Italy is to differentiate focal form of the disease from pancreatic cancer. The Italian diagnostic algorithm is therefore addressed to exclude cancer in this setting and, therefore, to safely use steroids. In diffuse form of the disease, the clinical problem is to differentiate AIP from acute nonnecrotizing pancreatitis and to exclude neoplasia (cholangiocarcinoma or lymphoma) in some cases.

In this chapter, we report the clinical profile of an Italian series of patients with AIP and highlight the main radiological and pathological findings.


Pancreatic Cancer Acute Pancreatitis Main Pancreatic Duct Autoimmune Pancreatitis Bile Duct Stenosis 


  1. 1.
    Finkelberg DL et al. Autoimmune pancreatitis. N Engl J Med. 2006;355(25):2670–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Yoshida K et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Ito T et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42(7):1458–68.PubMedCrossRefGoogle Scholar
  4. 4.
    Furukawa N et al. Autoimmune pancreatitis: radiologic findings in three histologically proven cases. J Comput Assist Tomogr. 1998;22(6):880–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Okazaki K et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118(3):573–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Frulloni L et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104(9):2288–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Chari ST et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39(5):549–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol. 2007;42 Suppl 18:39–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Ghazale A et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol. 2009;24(1):15–36.PubMedCrossRefGoogle Scholar
  11. 11.
    Frulloni L et al. A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol. 2011;17(16):2076–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Zamboni G et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445(6):552–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Deshpande V et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol. 2005;29(11):1464–71.PubMedCrossRefGoogle Scholar
  14. 14.
    Levy MJ et al. EUS-guided Tru-Cut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc. 2005;61(3):467–72.PubMedCrossRefGoogle Scholar
  15. 15.
    Khalid A et al. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol. 2006;101(11):2493–500.PubMedCrossRefGoogle Scholar
  16. 16.
    Levy MJ. Endoscopic ultrasound-guided Tru-Cut biopsy of the pancreas: prospects and problems. Pancreatology. 2007;7(2–3):163–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Detlefsen S et al. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 2009;454(5):531–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Mizuno N et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided Tru-Cut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44(7):742–50.PubMedCrossRefGoogle Scholar
  19. 19.
    Imai K et al. Endoscopic ultrasonography-guided fine needle aspiration biopsy using 22-gauge needle in diagnosis of autoimmune pancreatitis. Dig Liver Dis. 2011;43(11):869–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Iwashita T et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2012;10(3):316–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Manfredi R et al. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology. 2008;247(2):435–43.PubMedCrossRefGoogle Scholar
  22. 22.
    Manfredi R et al. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology. 2011;260(2):428–36.PubMedCrossRefGoogle Scholar
  23. 23.
    Graziani R et al. Autoimmune pancreatitis and non-necrotizing acute pancreatitis: computed tomography pattern. Dig Liver Dis. 2012;44(9):759–66.PubMedCrossRefGoogle Scholar
  24. 24.
    D’Onofrio M et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol. 2006;12(26):4181–4.PubMedGoogle Scholar
  25. 25.
    Okazaki K et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas. 2009;38(8):849–66.PubMedCrossRefGoogle Scholar
  26. 26.
    Otsuki M et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43(6):403–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Frulloni L, Lunardi C. Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence? Dig Liver Dis. 2011;43(9):674–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Shimosegawa T et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Frulloni L et al. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment. Pancreatology. 2010;10(2–3):129–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of MedicineUniversity of VeronaVeronaItaly
  2. 2.Servizio di Anatomia-Istologia PatologicaUniversità di Verona, Ospedale S.Cuore-Don CalabriaNegrar-VeronaItaly

Personalised recommendations